Abingdon Health Plc
Abingdon Health Plc (ABDXF) Revenue
Annual & quarterly revenue history · segment & region breakdown
ABDXF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsAbingdon Health Plc trailing twelve-month (TTM) revenue is $0.02B, an increase of 37.39% year-over-year from $0.01B in FY2025.
Revenue trend
2025 – 2018 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-06-30 | $0.01B | +$0.00B | +37.39% |
| 2024-06-30 | $0.01B | +$0.00B | +51.67% |
| 2023-06-30 | $0.00B | +$0.00B | +42.68% |
| 2022-06-30 | $0.00B | -$0.01B | -75.60% |
| 2021-06-30 | $0.01B | +$0.01B | +121.93% |
| 2020-06-30 | $0.01B | +$0.00B | +129.88% |
| 2019-06-30 | $0.00B | +$0.00B | +0.39% |
| 2018-06-30 | $0.00B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Abingdon Health Plc receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Abingdon Health Plc reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in GBP.
Data sourced from Abingdon Health Plc's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ABDXF revenue · 4 questionsABDXF's trailing twelve-month (TTM) revenue is $0.02B. That is an increase of 37.39% year-over-year from $0.01B in FY2025.
▸ Source: FMP · Abingdon Health Plc SEC filings · GAAP · Abingdon Health Plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026